Loading clinical trials...
Loading clinical trials...
A Phase IV, Randomized, Interventional, Study to Assess Subject Treatment Session Perception and Investigator Treatment Experience of Alluzience and Vacuum-Dried Botulinum Neurotoxin Type A for Aesthetic Use
Conditions
Interventions
Alluzience
powder BoNT-A (BOTOX/Vistabel)
Locations
8
Germany
Galderma Research Site 2003
Bochum, Germany
Galderma Research Site 2001
Düsseldorf, Germany
Galderma Research Site 2002
Düsseldorf, Germany
Galderma Research Site 1003
Edinburgh, United Kingdom
Galderma Research Site 1004
London, United Kingdom
Galderma Research Site 1006
London, United Kingdom
Start Date
February 4, 2022
Primary Completion Date
October 12, 2022
Completion Date
October 12, 2022
Last Updated
February 16, 2024
NCT05481931
NCT06411002
NCT05146999
NCT05148000
NCT04249583
NCT05217355
Lead Sponsor
Galderma R&D
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions